How do I buy Fulcrum Therapeutics (FULC) stock?

You can purchase shares of Fulcrum Therapeutics (NASDAQ:FULC) through any online brokerage.View our list of the best stock brokerages

Who are Fulcrum Therapeutics (FULC) competitors?

Other companies in Fulcrum Therapeutics’s space includes: Theravance Biopharma Inc (NASDAQ:TBPH), Zevra Therapeutics Inc (NASDAQ:ZVRA), GH Research PLC (NASDAQ:GHRS), SNDL Inc (NASDAQ:SNDL) and Bioage Labs Inc (NASDAQ:BIOA).

What is the forecast, or price target, for Fulcrum Therapeutics (FULC) stock?

Fulcrum Therapeutics has a consensus price target of $12.71.

What is the current price for Fulcrum Therapeutics (FULC)?

The stock price for Fulcrum Therapeutics (NASDAQ: FULC) is $9.94 last updated January 20, 2026 at 4:08 AM EST.

Does Fulcrum Therapeutics (FULC) pay a dividend?

There are no upcoming dividends for Fulcrum Therapeutics.

When is Fulcrum Therapeutics (NASDAQ:FULC) reporting earnings?

Fulcrum Therapeutics does not have any upcoming earnings scheduled.

Is Fulcrum Therapeutics (FULC) going to split?

There is no upcoming split for Fulcrum Therapeutics.

What sector and industry does Fulcrum Therapeutics (FULC) operate in?

Fulcrum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Fulcrum Therapeutics (FULC) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Pharmaceuticals

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule ...

Comments